The Federal Trade Commission fined Lumosity $2 million for deceptive advertising practices regarding its "brain training" games. Lumosity claimed its software could improve neuroplasticity and stave off Alzheimer's disease and dementia without scientific backing. The ads notably ran as underwriting on National Public Radio, despite strict rules against making health claims in public radio sponsorships.




